Advanced Basal Cell Carcinoma Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting advanced basal cell carcinoma clinical trials across 3 countries. Studies span Phase 2, Early Phase 1. Top locations include Tampa, Florida, United States, Angers, France, Annecy, France. Updated daily from ClinicalTrials.gov.


Advanced Basal Cell Carcinoma Trials at a Glance

7 actively recruiting trials for advanced basal cell carcinoma are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Tampa, Angers, and Annecy. Lead sponsors running advanced basal cell carcinoma studies include Maastricht University Medical Center, Mayo Clinic, and H. Lee Moffitt Cancer Center and Research Institute.

Browse advanced basal cell carcinoma trials by phase

Treatments under study

About Advanced Basal Cell Carcinoma Clinical Trials

Looking for clinical trials for Advanced Basal Cell Carcinoma? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Basal Cell Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Basal Cell Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Locally Advanced Basal Cell Carcinoma
Philogen S.p.A.180 enrolled3 locationsNCT07227350
Recruiting

French National Database of Rare Dermatological Cancers

Merkel Cell CarcinomaAdnexal Tumor of SkinAdvanced Basal Cell Carcinoma Requiring Systemic Treatment
University Hospital, Lille9,000 enrolled34 locationsNCT03210935
Recruiting
Phase 2

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Advanced Colorectal CarcinomaAdvanced Anal CarcinomaAdvanced Biliary Tract Carcinoma+41 more
Mayo Clinic220 enrolled2 locationsNCT05969860
Recruiting
Early Phase 1

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute34 enrolled1 locationNCT05651828
Recruiting

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Locally Advanced Merkel Cell CarcinomaLocally Advanced Mucosal MelanomaClinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center70 enrolled1 locationNCT07215988
Recruiting
Phase 2

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
Thomas Jefferson University70 enrolled3 locationsNCT05929664
Recruiting

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

CarcinomaSkin CancerBasal Cell Carcinoma+8 more
Maastricht University Medical Center80 enrolled8 locationsNCT05463757